Contact
searchSearch
HMP Global

Stomach and Small Bowel Diseases Excellence Forum

Stomach and Small Bowel Diseases
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Brian Lacy
Conference Coverage
Brian Lacy, MD, on Functional Dyspepsia and Gastroparesis
10/27/2025
Brian E. Lacy, PhD, MD
Dr Lacy reviews his presentation from the ACG conference on the challenges of distinguishing functional dyspepsia and gastroparesis and finding the best treatments for these conditions.
Dr Lacy reviews his presentation from the ACG conference on the challenges of distinguishing functional dyspepsia and gastroparesis and finding the best treatments for these conditions.
Dr Lacy reviews his presentation...
10/27/2025
Gastroenterology
Christopher Velez
Conference Coverage
Christopher Velez, MD, on SIBO
10/27/2025
Christopher Velez, MD
Dr Velez discusses his presentation on the who, the what, and the when to treat issues around small intestinal bacterial overgrowth.
Dr Velez discusses his presentation on the who, the what, and the when to treat issues around small intestinal bacterial overgrowth.
Dr Velez discusses his...
10/27/2025
Gastroenterology
Gut Check logo
Podcast
Gut Check: Vivek Kumbari, MD, on Third Space Endoscopy
09/23/2025
Brian E. Lacy, PhD, MD
Dr Vivek Kumbari and Dr Brian Lacy discuss the evolution of third-space endoscopy and how it has enabled quicker, simpler and safer procedures throughout the gastrointestinal tract, as well as the potential future of endoscopy as primarily a...
Dr Vivek Kumbari and Dr Brian Lacy discuss the evolution of third-space endoscopy and how it has enabled quicker, simpler and safer procedures throughout the gastrointestinal tract, as well as the potential future of endoscopy as primarily a...
Dr Vivek Kumbari and Dr Brian...
09/23/2025
Gastroenterology
Gut Check logo
Podcast
Dr Micheal Tadros on GLP-1 Agonists in Gastroenterology
05/28/2025
Brian E. Lacy, PhD, MD; Micheal Tadros, MD
Dr Brian Lacy hosts Dr Micheal Tadros in a discussion of the increasing use of glucagon-like receptor 1 agonists and how use of these drugs can affect the gastro intestinal system for positively and negatively.
Dr Brian Lacy hosts Dr Micheal Tadros in a discussion of the increasing use of glucagon-like receptor 1 agonists and how use of these drugs can affect the gastro intestinal system for positively and negatively.
Dr Brian Lacy hosts Dr Micheal...
05/28/2025
Gastroenterology
Gut Check logo
Podcast
Gut Check: Hypermobility and Gastric Disorders with Dr Dacre Knight
03/10/2025
Brian E. Lacy, PhD, MD; Dacre Knight, MD
Dr Dacre Knight provides insights into hypermobility syndromes and their relationships to disorders of gut-brain interaction and gastrointestinal symptoms in the latest Gut Check, hosted by Dr Brian Lacy.
Dr Dacre Knight provides insights into hypermobility syndromes and their relationships to disorders of gut-brain interaction and gastrointestinal symptoms in the latest Gut Check, hosted by Dr Brian Lacy.
Dr Dacre Knight provides...
03/10/2025
Gastroenterology
Gut Check logo
Podcast
Gut Check: Michael Wallace, MD, on AI in GI
02/04/2025
Brian E. Lacy, PhD, MD
Host Brian Lacy, MD, is joined by Dr Michael Wallace to discuss the present and future applications of artificial intelligence in the practice of gastroenterology.
Host Brian Lacy, MD, is joined by Dr Michael Wallace to discuss the present and future applications of artificial intelligence in the practice of gastroenterology.
Host Brian Lacy, MD, is joined...
02/04/2025
Gastroenterology
Amy Oxentenko
Video
Amy Oxentenko, MD, on Updates in Celiac Disease
01/02/2025
Amy Oxentenko, MD
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into...
01/02/2025
Gastroenterology
Gut Check logo
Podcast
Gut Check: Sam Han, MD, on Pancreatitis
12/05/2024
Brian E. Lacy, PhD, MD
In this episode of Gut Check, Dr Brian Lacy talks with Dr Samuel Han from the Mayo Clinic about the etiology, risk factors, diagnosis, and treatment of chronic pancreatitis.
In this episode of Gut Check, Dr Brian Lacy talks with Dr Samuel Han from the Mayo Clinic about the etiology, risk factors, diagnosis, and treatment of chronic pancreatitis.
In this episode of Gut Check, Dr...
12/05/2024
Gastroenterology
Gut Check logo
Podcast
Gut Check: Drs Brian Lacy and Satish Rao on Constipation
10/11/2024
Brian E. Lacy, PhD, MD
Host Brian Lacy, MD, reviews the diagnosis and treatment of acute and chronic constipation with Dr Satish Rao.
Host Brian Lacy, MD, reviews the diagnosis and treatment of acute and chronic constipation with Dr Satish Rao.
Host Brian Lacy, MD, reviews the...
10/11/2024
Gastroenterology
Gut Check
Podcast
Gut Check: Anne Peery, MD, on Diverticulosis
10/03/2024
Brian E. Lacy, PhD, MD; Anne Peery, MD
Host Brian Lacy, MD, discusses the diagnosis, treatment, and prevention of diverticular disease with Dr Anne Peery in the latest episode of Gut Check.
Host Brian Lacy, MD, discusses the diagnosis, treatment, and prevention of diverticular disease with Dr Anne Peery in the latest episode of Gut Check.
Host Brian Lacy, MD, discusses...
10/03/2024
Gastroenterology

News

News
GI Symptoms More Prevalent Among Hospitalized COVID+ Patients
02/03/2022
A recent study found that the prevalence of gastrointestinal symptoms in patients hospitalized for COVID-19 is higher than has been previously reported.
A recent study found that the prevalence of gastrointestinal symptoms in patients hospitalized for COVID-19 is higher than has been previously reported.
A recent study found that the...
02/03/2022
Gastroenterology
Research Highlights
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology
Research Highlights
Tinegotinib Monotherapy Shows Efficacy Among Patients With Advanced/Metastatic Cholangiocarcinoma
10/01/2025
Stephanie Holland
An ongoing randomized, controlled phase III study will evaluate the clinical efficacy, safety, and pharmacodynamic effect of tinengotinib for refractory/relapsed cholangiocarcinoma.
An ongoing randomized, controlled phase III study will evaluate the clinical efficacy, safety, and pharmacodynamic effect of tinengotinib for refractory/relapsed cholangiocarcinoma.
An ongoing randomized,...
10/01/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use